Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
Immune thrombocytopenia
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
